Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR   US00484M1062

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/25/2014 08/26/2014 08/27/2014 08/28/2014 08/29/2014 Date
32.36(c) 32.73(c) 33.01(c) 32.29(c) 32.58(c) Last
373 269 423 214 475 205 240 223 140 295 Volume
+2.73% +1.14% +0.86% -2.18% +0.90% Change
More quotes
Company
Acorda Therapeutics, Inc. engages in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system. The company's two main products are Ampyra and Zanaflex... 
Sector
Biotechnology & Medical Research
Calendar
09/09 | 02:05pmPresentation
Surperformance© rating of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More about the company
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 369 M
EBIT 2014 24,9 M
Net income 2014 9,09 M
Debt 2014 -
Yield 2014 -
Sales 2015 408 M
EBIT 2015 48,6 M
Net income 2015 29,7 M
Debt 2015 -
Yield 2015 -
PER 2014 129,80
PER 2015 57,49
Capi. / Sales 2014 3,68x
Capi. / Sales 2015 3,33x
Capitalization 1 360 M
More Financials
Latest news on ACORDA THERAPEUTICS INC
2d ago ACORDA THERAPEUTICS : "Carbonate Prodrugs and Methods of Using the Same" in Pate..
3d ago ACORDA THERAPEUTICS : to Present at the Baird 2014 Healthcare Conference
5d ago ACORDA THERAPEUTICS : Digital Agency StudioPMG Partners with Acorda on Multiple ..
08/23 ACORDA THERAPEUTICS : New coaching program helps people living with multiple scl..
08/14 ACORDA THERAPEUTICS : Updates on Second Quarter 2014 Financial Results
08/07 ACORDA THERAPEUTICS : Releases Second Quarter 2014 Financial Results
08/06 ACORDA THERAPEUTICS : Reports Second Quarter 2014 Financial Results
08/01 ACORDA THERAPEUTICS : Reports Second Quarter 2014 Financial Results
07/31 ACORDA THERAPEUTICS : Results of Operations and Financial Condition, Financial S..
07/31 ACORDA THERAPEUTICS : Reports Second Quarter 2014 Financial Results
07/30 ACORDA THERAPEUTICS : Patent Issued for Compositions and Methods for Promoting N..
07/28 ACORDA THERAPEUTICS : Assigned Patent
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
Acorda Therapeutics Inc : Income Statement Evolution
More Financials
EPS Revisions
Acorda Therapeutics Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF